Last week, the Nevada Department of Health and Human Services released the results of an actuarial study projecting hundreds of millions of dollars in savings from the state’s Public Option plans within the program’s first few years. CHIR’s Christine Monahan takes a look at the estimated impact of the state’s public option-style law.
Hospitals and health insurers are now required to publicly post their prices for health care services. However, as Maanasa Kona and Sabrina Corlette observe in their latest Health Affairs Forefront blog, the new disclosure requirements have not – yet – translated into data that can be used to identify the drivers of health care cost growth. Their piece identifies options for federal and state regulators to improve compliance and ultimately help support informed health care purchasing and policy decisions.
Last month, the Federal Trade Commission (FTC) took action against Benefytt Technologies, finding the company relied on deceptive websites, high-pressure sales tactics, and misleading information to push consumers into enrolling in junk plans, and then made it difficult for consumers to cancel their coverage. CHIR’s prior research on the marketing of junk plans shows that these tactics are neither new nor unique.
A federal judge in Texas has ruled that Affordable Care Act requirements that insurers cover and waive cost-sharing for preventive services is unconstitutional. While the case is likely to be appealed, states can act now to preserve residents’ access to affordable and often life-saving preventive care. In a new Expert Perspective for the State Health & Value Strategies project, Sabrina Corlette and Justin Giovannelli outline how.
For the August edition of our monthly research roundup, CHIR said farewell to summer by reviewing the latest health policy research. This month, we summarize studies on how the end of the COVID-19 public health emergency (PHE) will impact health coverage, global efforts to achieve universal health coverage, and the effects of eliminating nominal marketplace premiums.
CHIR is delighted to welcome three new faculty members to our team: Research Professor Linda Blumberg, Senior Research Fellow Karen Davenport, and Assistant Research Professor Vrudhi Raimugia.
For the third time, the Department of Health and Human Services’ Office of Civil Rights has proposed rules to effectuate the application of civil rights protections to the health care industry under Section 1557 of the Affordable Care Act. If finalized, the regulation will have significant implications for health insurers and provide important nondiscrimination protections for insurance enrollees.
The Biden administration has published its final rules governing the independent dispute resolution process outlined in the No Surprises Act. In a new Expert Perspective for the State Health & Value Strategies project, CHIR’s Jack Hoadley, Kevin Lucia, and JoAnn Volk review the rule and its implications for state regulators.
The affordability of diabetes care is a national issue. Even with insurance, diabetic patients can spend thousands of dollars on medication, supplies, and health services. These costs can present a particular burden on Black families. Black and Hispanic patients face disproportionally high hospitalizations and emergency department visits due to diabetes complications, emphasizing that affordable access to diabetes care is an issue of health equity. In a new post for the Commonwealth Fund, CHIR experts highlight different approaches states are taking to reduce health care disparities for diabetic patients.
As the number of opioid-related overdose fatalities remains alarmingly high, access to medication-assisted treatment (MAT) is inconsistent. Private insurance does not always cover the full range of MAT options, and when it does provide coverage cost sharing can be prohibitive. CHIR’s Rachel Swindle takes a look at state and federal reforms that can help lessen private insurance related barriers to treatment.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
